Waleed H. Hassanein - 06 Aug 2025 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: President & CEO, Director
Signature: By: /s/ Gerardo Hernandez, Attorney-in-Fact
Issuer symbol: TMDX
Transactions as of: 06 Aug 2025
Net transactions value: +$1,982,121
Form type: 4
Filing time: 08 Aug 2025, 16:30:13 UTC
Previous filing: 26 Feb 2025
Next filing: 18 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hassanein Waleed H	President & CEO, Director	C/O TRANSMEDICS GROUP, INC., 200 MINUTEMAN ROAD, ANDOVER	By: /s/ Gerardo Hernandez, Attorney-in-Fact	08 Aug 2025	0001430466

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Purchase	$996,912	+8,400	+1.8%	$118.68	477,759	06 Aug 2025	By the Waleed H. Hassanein Revocable Trust	F1
transaction	TMDX	Common Stock	Purchase	$768,101	+6,617	+1.4%	$116.08	484,376	07 Aug 2025	By the Waleed H. Hassanein Revocable Trust	F2
transaction	TMDX	Common Stock	Purchase	$217,107	+1,858	+0.38%	$116.85	486,234	07 Aug 2025	By the Waleed H. Hassanein Revocable Trust	F3
holding	TMDX	Common Stock						121,424	06 Aug 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $118.50 to $118.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2	The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $115.60 to $116.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F3	The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $116.62 to $117.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.